INTRODUCTION Antimicrobial Resistance in N. gonorrhoeae An Overview KEY ISSUES Gonococcal infections have been resistant to certain antimicrobial drugs Potential increase in major sequelae due to prolonged duration of original infection
"INTRODUCTION Antimicrobial Resistance in N." is the property of its rightful owner. Permission is granted to
download and print the materials on this website for personal, non-commercial use only, and to display it
on your personal computer provided you do not modify the materials and that you retain all copyright
notices contained in the materials. By downloading content from our website, you accept the terms of this
agreement.
Presentation Transcript
01
INTRODUCTION Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
02
KEY ISSUES Gonococcal infections have been resistant to certain antimicrobial drugs Potential increase in major sequelae due to prolonged duration of original infection Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
03
KEY ISSUES Antimicrobial Resistance in N. gonorrhoeae – An Overview * Men Who Have Sex With Men<br>
04
KEY ISSUES Unfortunately the use of NAAT has resulted in less data on antimicrobial susceptibility Why? High specificity & sensitivity Cost-effective Cultures are impractical Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
05
DIAGNOSIS Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
06
DIAGNOSIS Cultures are particularly important in the following situations: Where there is an increased probability or a suspected treatment failure If the infection was acquired in a geographical area with high rates of antimicrobial resistance Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
07
TREATMENT Agency’s Recommended Treatment 2013 Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
08
TREATMENT Full treatment details at:
http://www.The Agency-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/section-5-6-eng.php Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
09
TREATMENT Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
10
Case has persistent symptoms or signs post-therapy TEST OF CURE Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
11
TEST OF CURE Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
12
TREATMENT FAILURE Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
13
Should I notify local public health officials? REPORTING When treatment failure has occurred? Gonorrhea is a reportable infection. Treatment failure should also be reported. For cases of gonorrhea? Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
14
RESOURCES http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/section-5-6-eng.php
The above based on Public Health Agency of Canada’s Canadian STI Guidelines To access the chapter and additional resources: This document is intended to provide information to public health and clinical professionals and does not supersede any provincial/territorial legislative, regulatory, policy and practice requirements or professional guidelines that govern the practice of health professionals in their respective jurisdictions, whose recommendations may differ due to local epidemiology or context. Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
15
CONCLUSION To successfully address the public health risk of antimicrobial resistant gonorrhea, all primary care and public health professionals must work together. Antimicrobial Resistance in N. gonorrhoeae – An Overview<br>
